Logo image of CXE

MFS HIGH INCOME MUNICIPAL TR (CXE) Stock Price, Quote, News and Overview

NYSE:CXE - New York Stock Exchange, Inc. - US59318D1046 - Currency: USD

3.795  +0.02 (+0.4%)

Fundamental Rating

1

CXE gets a fundamental rating of 1 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. CXE has a bad profitability rating. Also its financial health evaluation is rather negative. CXE has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

CXE had positive earnings in the past year.
CXE had a positive operating cash flow in the past year.
Of the past 5 years CXE 4 years were profitable.
Each year in the past 5 years CXE had a positive operating cash flow.
CXE Yearly Net Income VS EBIT VS OCF VS FCFCXE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M

1.2 Ratios

Industry RankSector Rank
ROA 1.17%
ROE 1.94%
ROIC 1.86%
ROA(3y)-3.38%
ROA(5y)-0.77%
ROE(3y)-5.74%
ROE(5y)-1.46%
ROIC(3y)2.05%
ROIC(5y)2.17%
CXE Yearly ROA, ROE, ROICCXE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 -10 -20

1.3 Margins

In the last couple of years the Profit Margin of CXE has declined.
CXE's Operating Margin has declined in the last couple of years.
In the last couple of years the Gross Margin of CXE has declined.
Industry RankSector Rank
OM 47.73%
PM (TTM) 23.94%
GM 46.96%
OM growth 3Y-10.44%
OM growth 5Y-6.43%
PM growth 3Y50.09%
PM growth 5Y-5.85%
GM growth 3Y-10.82%
GM growth 5Y-6.75%
CXE Yearly Profit, Operating, Gross MarginsCXE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100 -100 -200 -300

More info and screens

1

2. Health

2.1 Basic Checks

Compared to 1 year ago, CXE has about the same amount of shares outstanding.
CXE has about the same amout of shares outstanding than it did 5 years ago.
The debt/assets ratio for CXE has been reduced compared to a year ago.
CXE Yearly Shares OutstandingCXE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 10M 20M 30M
CXE Yearly Total Debt VS Total AssetsCXE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

Based on the Altman-Z score of 0.78, we must say that CXE is in the distress zone and has some risk of bankruptcy.
CXE has a debt to FCF ratio of 8.15. This is a slightly negative value and a sign of low solvency as CXE would need 8.15 years to pay back of all of its debts.
A Debt/Equity ratio of 0.65 indicates that CXE is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 8.15
Altman-Z 0.78
ROIC/WACCN/A
WACCN/A
CXE Yearly LT Debt VS Equity VS FCFCXE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.3 Liquidity

CXE has a Current Ratio of 0.36. This is a bad value and indicates that CXE is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.36 indicates that CXE may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0.36
Quick Ratio 0.36
CXE Yearly Current Assets VS Current LiabilitesCXE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M

More info and screens

1

3. Growth

3.1 Past

CXE shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 107.15%, which is quite impressive.
CXE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -11.09% yearly.
CXE shows a small growth in Revenue. In the last year, the Revenue has grown by 5.73%.
The Revenue has been decreasing by -5.81% on average over the past years.
EPS 1Y (TTM)107.15%
EPS 3Y45.29%
EPS 5Y-11.09%
EPS Q2Q%104.31%
Revenue 1Y (TTM)5.73%
Revenue growth 3Y-3.2%
Revenue growth 5Y-5.81%
Sales Q2Q%3.4%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CXE Yearly Revenue VS EstimatesCXE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 5M 10M
CXE Yearly EPS VS EstimatesCXE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

CXE is valuated quite expensively with a Price/Earnings ratio of 47.44.
CXE's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.63.
Industry RankSector Rank
PE 47.44
Fwd PE N/A
CXE Price Earnings VS Forward Price EarningsCXE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 11.97
EV/EBITDA N/A
CXE Per share dataCXE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

CXE has a Yearly Dividend Yield of 4.56%, which is a nice return.
CXE's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 4.56%

5.2 History

The dividend of CXE decreases each year by -11.23%.
CXE has paid a dividend for at least 10 years, which is a reliable track record.
CXE has decreased its dividend recently.
Dividend Growth(5Y)-11.23%
Div Incr Years1
Div Non Decr Years1
CXE Yearly Dividends per shareCXE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3

5.3 Sustainability

203.84% of the earnings are spent on dividend by CXE. This is not a sustainable payout ratio.
CXE's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP203.84%
EPS Next 2YN/A
EPS Next 3YN/A
CXE Yearly Income VS Free CF VS DividendCXE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10M -10M -20M -30M
CXE Dividend Payout.CXE Dividend Payout, showing the Payout Ratio.CXE Dividend Payout.PayoutRetained Earnings

More info and screens

MFS HIGH INCOME MUNICIPAL TR

NYSE:CXE (2/21/2025, 8:11:31 PM)

3.795

+0.02 (+0.4%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners41.23%
Inst Owner Change1.34%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap119.66M
Analysts0
Price TargetN/A
Short Float %0.02%
Short Ratio0.07
Dividend
Industry RankSector Rank
Dividend Yield 4.56%
Yearly Dividend0.16
Dividend Growth(5Y)-11.23%
DP203.84%
Div Incr Years1
Div Non Decr Years1
Ex-Date02-18 2025-02-18 (0.016)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 47.44
Fwd PE N/A
P/S 11.69
P/FCF 11.97
P/OCF 11.97
P/B 0.95
P/tB 0.95
EV/EBITDA N/A
EPS(TTM)0.08
EY2.11%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.32
FCFY8.36%
OCF(TTM)0.32
OCFY8.36%
SpS0.32
BVpS4
TBVpS4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.17%
ROE 1.94%
ROCE 2.35%
ROIC 1.86%
ROICexc 1.86%
ROICexgc 1.86%
OM 47.73%
PM (TTM) 23.94%
GM 46.96%
FCFM 97.64%
ROA(3y)-3.38%
ROA(5y)-0.77%
ROE(3y)-5.74%
ROE(5y)-1.46%
ROIC(3y)2.05%
ROIC(5y)2.17%
ROICexc(3y)2.05%
ROICexc(5y)2.17%
ROICexgc(3y)2.05%
ROICexgc(5y)2.17%
ROCE(3y)2.6%
ROCE(5y)2.74%
ROICexcg growth 3Y-6.33%
ROICexcg growth 5Y-7.75%
ROICexc growth 3Y-6.33%
ROICexc growth 5Y-7.75%
OM growth 3Y-10.44%
OM growth 5Y-6.43%
PM growth 3Y50.09%
PM growth 5Y-5.85%
GM growth 3Y-10.82%
GM growth 5Y-6.75%
F-Score6
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.65
Debt/FCF 8.15
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 407.82%
Current Ratio 0.36
Quick Ratio 0.36
Altman-Z 0.78
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)107.15%
EPS 3Y45.29%
EPS 5Y-11.09%
EPS Q2Q%104.31%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.73%
Revenue growth 3Y-3.2%
Revenue growth 5Y-5.81%
Sales Q2Q%3.4%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-17.04%
EBIT growth 3Y-13.31%
EBIT growth 5Y-11.86%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-42.49%
FCF growth 3Y9.48%
FCF growth 5Y1.99%
OCF growth 1Y-42.49%
OCF growth 3Y9.48%
OCF growth 5Y1.99%